Trump-touted Covid-19 antibody treatments: what we know

Washington (AFP) – Two US companies have applied for emergency approval for their lab-produced antibodies against Covid-19 — and President Donald Trump has signaled his strong backing based on the fact he was treated with one of them.Here’s what we know about the treatments and why the perception of political interference at the Food and Drug Administration may have eroded public trust.What are they? – The therapies developed by Regeneron and Eli Lilly are called “monoclonal antibodies,” a relatively new class of drugs that are best known for treating certain types of cancer and autoimmune di…

Read More

HEDGE accordingly